Join our
mailing list

Be the first to receive exciting updates, including offers and discounts by singing up below

What are you waiting for?

From less than £35/week - start your Wegovy or Mounjaro Journey with SemaPen!

Losing Weight Just Got Easier with SemaPen

Digital Weight Loss Programme Designed by Clinical Experts

15%

average body weight lost in a year *

27

lower BMI cut off for treatment †

95%

chance of responding to treatment

15%

average body weight lost in a year *

27

lower BMI cut off for treatment †

95%

chance of responding to treatment

LJ

16/10/2023 - Trustpilot - 5 ★

"Losing weight has never been easier! They offer a reliable supply of Wegovy and a great team that helped me for the past month!"

Rachel

07/11/2023 - Trustpilot - 5 ★

"The support, help and advice from the team has been amazing and it’s quick and easy to communicate with them with any questions, they reply very quickly and solve any concerns I may have. Many thanks Semapen"

Sue

20/11/2023 - Trustpilot - 5 ★

"Am over the moon with the weight loss. Thank you."

Priyanka

18/10/2023 - Trustpilot - 5 ★

"The scales keep me on track, as do the other resources such as the recipes etc. Thanks to the team."

Chris

07/02/2024 - Trustpilot - 5 ★

"Been with Semapen for a couple of months now and have seen some wonderful results. I started on 95.6kg and this morning already down to 90.4kg so yes really excited. Have a target weight to achieve which I'm well on the way there but my confidence has improved and im really happy. Customer service has been great, response times excellent too. Nothing negative to report back as of yet. Many many thanks to the Semapen team"

Teresa

08/02/2024 - Trustpilot - 5 ★

"Been on semapen now for 3 weeks. The honest truth is I wasn't expecting it to work but it's absolutely amazing. I've already lost 8lb and having the app and scales to follow my progress is helping to keep me motivated. I never expected it to be this good. I feel amazing everyday. Highly Highly recommend and excited every morning checking my new weight."

David

22/11/2023 - Trustpilot - 5 ★

"Absolutely delighted with the results so far, Only on First month and dropped around 8lbs so this is really encouraging progress, Happy to continue with SemaPen and wouldn’t hesitate to recommend to others."

Emily

15/11/2023 - Trustpilot - 5 ★

"Ordered on Friday 10th November, scales received Monday 13th November, Wegovy received Tuesday 14th November. Very happy with the service so far."

Find Out How We Can Help

See what 15% Weight Loss* would look like for you

After 12 months you could weigh

Results vary - weight loss can be more or less than 15% average.

Why Choose SemaPen?

Safe and Effective Treatment

Wegovy is a  revolutionary new treatment that’s clinically proven to control appetite and reduce body weight by an average of 15%*.

But with more than 15 years experience specialising in obesity treatment, we can tell you that you’ll need more than just an injection to succeed long term. That’s where the SemaPen programme comes in.

Digital Smart Scales

We’ll provide you with a sleek Withings® Body smart scale (worth £60) that’s linked to our unique SemaPen app via the cloud,  giving you and our support team real-time oversight of your progress.

Weight Loss Experts

You’ll get exclusive access to personalised support from experts in obesity care (not pharmacists or GPs). Our team of doctors, dietitians, nurses and psychologists use SemaPen’s technology to make sure you stay on track for a great outcome.

And if you’re struggling, we’re there to give you extra help with targeted feedback and advice.

 

Convenient and Discreet

We offer a free detailed online  assessment you can complete at any time.  This determines if you’re suitable for the treatment. There’s no need to book an online appointment or visit a clinic, GP or pharmacy.

If the SemaPen programme is right for you, we’ll discreetly send your medication and Withings smart scales straight to your door.  

Our subscription service means you don’t even have to remember to order repeat prescriptions – we take care of all that for you.

Safe and Effective Treatment

Wegovy is a  revolutionary new treatment that’s clinically proven to control appetite and reduce body weight by an average of 15%*.

But with more than 15 years experience specialising in obesity treatment, we can tell you that you’ll need more than just an injection to succeed long term. That’s where the SemaPen programme comes in.

Digital Smart Scales

We’ll provide you with a sleek Withings® Body smart scale (worth £60) that’s linked to our unique SemaPen app via the cloud,  giving you and our support team real-time oversight of your progress.

Weight Loss Experts

You’ll get exclusive access to personalised support from experts in obesity care (not pharmacists or GPs). Our team of doctors, dietitians, nurses and psychologists use SemaPen’s technology to make sure you stay on track for a great outcome.

And if you’re struggling, we’re there to give you extra help with targeted feedback and advice.

 

Convenient and Discreet

We offer a free detailed online  assessment you can complete at any time.  This determines if you’re suitable for the treatment. There’s no need to book an online appointment or visit a clinic, GP or pharmacy.

If the SemaPen programme is right for you, we’ll discreetly send your medication and Withings smart scales straight to your door.  

Our subscription service means you don’t even have to remember to order repeat prescriptions – we take care of all that for you.

The SemaPen Programme

Free online self-assessment tool

Our free comprehensive medical consultation is designed by doctors and available 24/7. Find out in minutes if you are suitable for our programme

Order Online

Order your prescription online*. No need to visit a clinic or pharmacy. Discreet delivery to your home.  

*Once accepted onto the SemaPen programme

Money back guarantee

Receive a refund if you don't lose at least 5% of your starting weight after completing the 12-month SemaPen programme**  

**Terms and conditions apply

Cancel Anytime

You can change your mind or cancel your subscription anytime**  

**Terms and conditions apply.

Supported by ClinicalExperts

Read what leading weight management professionals had to say about Wegovy:

GLP-1 agonists have transformed the treatment of obesity, particularly for those with BMIs of 27-40 who are not eligible for, or wish to avoid, bariatric surgery. Used in conjunction with a high quality support programme, the chance of achieving clinically beneficial weight loss is high.

Professor David Kerrigan

SemaPen Founder and Bariatric Expert

We all know that losing weight and keeping it off is difficult. But GLP-1 agonists enhance natural signals between the gut and the brain that make you feel full sooner, and could help you achieve and maintain weight loss

Professor John Wilding

Professor of Medicine, University of Liverpool

The Semapen Programme is a new digital weight loss solution that integrates state-of-the-art medication, behaviour change techniques, and healthy eating. With a comprehensive approach tailored to your needs, SemaPen empowers you to achieve sustainable weight loss and embrace a healthier lifestyle.

Lujain Alhassan

Nutritionist at SemaPen

Wegovy is a very effective treatment, not just in weight loss, but used to improve blood glucose levels with people living with Type 2 Diabetes. As an added bonus, they have shown some benefits in improving cardiac and kidney health.

Davina Morrell

Specialist Obesity & Diabetes Nurse at SemaPen

Clinically proven, non-invasive treatments offer hope for individuals struggling with obesity. Studies show that when combined with appropriate support and lifestyle modifications, this treatment holds immense potential to facilitate remarkable weight loss and bring about significant improvements to overall health and well-being.

Kiara Lipschitz

Dietitian at SemaPen

Weight loss requires determination, consistency and hard work, but weight loss injections like Wegovy can provide those struggling with obesity with a safe tool to make this a much easier process

Anjana Odedra

Lead Pharmacist at SemaPen

There are multiple factors which contribute towards difficulties in losing and maintaining weight loss. Weight loss injections can be a helpful tool in supporting people to make changes to the ways that they eat, respond to internal cues and their relationship with food.

Hannah Jerome

Psychologist at SemaPen

David Kerrigan has provided expert commentary on obesity-related matters for

FAQs

Here are answers to some of the most commonly asked questions about The SemaPen Programme.

For a more detailed list of FAQs please select ‘FAQS’ from the top menu or footer below

How much weight will I lose?

Reputable clinical trials* found that if you use weight loss injections as part of a comprehensive weight loss programme involving dietetic support and lifestyle modification (calorie restriction and some regular exercise) an average outcome is to lose about 15% of starting body weight after a year. It is unlikely that you will achieve this amount of weight loss with the injection alone, which is why the 12-month SemaPen programme is so important.

Remember, 15% weight loss was the average outcome, but some people in the trials lost more than this and others will have lost less.

Will I lose all enjoyment of food if I use weight loss injections?

Absolutely not!

Wegovy does not alter the taste of food, they work by suppressing your appetite.  You will also start to feel full much sooner than normal. This dual action makes it much easier for you to avoid snacking and to control the size of your main meals.

You can still enjoy the pleasure of lovely food, but they put you in control so you are able to moderate your calorie intake.

 

Will I have side effects?

Like all medications, Wegovy may cause side effects. The most common include nausea, bloating and constipation (sometimes accompanied by abdominal pains).  This is because one of the ways Wegovy helps is by slowing down how fast the stomach and intestine empty, which contributes to a sense of early and more prolonged fullness after meals.

These symptoms are typically worse when starting treatment and for the first few days after moving up to a higher dose pen. Most people (>95%) find them fairly easy to tolerate, particularly as they tend to improve over time. However if they persist it’s important to seek medical advice.

Am I suitable for The SemaPen Programme?

Wegovy is approved for use in adults with a BMI of 30 or higher, although there are certain medical conditions that would make treatment inadvisable.

This BMI cut off is lowered to 27  for those who also have at least one weight-related condition.  Some examples include high blood pressure, type 2 diabetes, high cholesterol, sleep apnoea, gastro-oesophageal reflux, weight-related depression or joint pain.  We will ask you about this as part of the onboarding process.

People of certain ethnic origins (Asian, Black Afro-Caribbean, Arabs) are more prone to developing type 2 diabetes and cardiovascular complications of obesity at lower BMIs than Caucasians and this may be taken into account when deciding if you are suitable for treatment.

Complete our free, online medical questionnaire to determine whether you are suitable for the SemaPen programme.

Can I get it on the NHS?

It is likely that Wegovy will be made available on the NHS at some point, but NICE has advised that NHS patients must have a BMI greater than 35 AND at least one weight-related medical condition such as type 2 diabetes*.

It is only under exceptional circumstances that the NHS will prescribe the treatment to people with a BMI of 30-35, even if they do have medical conditions.

*https://www.nice.org.uk/news/article/nice-recommends-new-drug-for-people-living-with-obesity

 

*Wilding, J.P.H. et al. (2021) “Once-weekly semaglutide in adults with overweight or obesity,” New England Journal of Medicine, 384(11). https://doi.org/10.1056/NEJMoa2032183

† In the presence of weight related conditions, otherwise lower BMI cut-off is 30. Lower BMI threshold apply to some ethnic groups.